Sodium Chloride Injection, Solution
NDC Package 64253-202-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Sodium Chloride injection is this solution is used to supply water and salt (sodium chloride) to the body. This formulation utilizes a injection, solution delivery system. Marketed by Medefil, Inc., this product is identified by NDC 64253-202 and is authorized under FDA application NDA202832.

Identification & Billing

NDC Package Code
64253-202-30
Package Description
60 SYRINGE, PLASTIC in 1 BOX / 10 mL in 1 SYRINGE, PLASTIC
Product Code
64253-202
11-Digit Billing Format
64253020230
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Sodium Chloride
Non-Proprietary Name
Sodium Chloride
Substance Name
Sodium Chloride
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
SODIUM CHLORIDE 9 mg/mL
Pharmacologic Class
Usage Information
This solution is used to supply water and salt (sodium chloride) to the body. Sodium chloride solution may also be mixed with other medications given by injection into a vein.

Regulatory & Marketing

Labeler Name
Medefil, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA202832
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-13-2012
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64253-202-30 identifies a specific commercial package of 60 syringe, plastic in 1 box / 10 ml in 1 syringe, plastic of Sodium Chloride, a human prescription drug labeled by Medefil, Inc.. This injection, solution is formulated for intramuscular; intravenous; subcutaneous use and contains sodium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medefil, Inc. on January 13, 2012. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This solution is used to supply water and salt (sodium chloride) to the body. Sodium chloride solution may also be mixed with other medications given by injection into a vein.

How is this Medefil, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64253020230. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
64253-202-30
11-Digit CMS (5-4-2)
64253-0202-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.